Santa Monica-based nootropics producer TruBrain is expanding into the CBD marketplace with a new product that combines its patent-pending smart drug formula with the increasingly popular hemp extract. To help finance this expansion, the company launched a crowdfunding campaign that offers an ownership stake in the business to everyday investors. The goal of the campaign,
Santa Monica-based nootropics producer TruBrain is expanding into the CBD marketplace with a new product that combines its patent-pending smart drug formula with the increasingly popular hemp extract.
To help finance this expansion, the company launched a crowdfunding campaign that offers an ownership stake in the business to everyday investors. The goal of the campaign, which is hosted on the StartEngine platform, is to raise $1 million in new capital.
Trubrain previously raised $1.6 million from venture capital firms and angel investors, and reached profitability earlier this year, surpassing $12 million in lifetime sales of its cognitive enhancement products.
“Our mission is to help people do their best thinking – that’s why we are excited about CBD,” founder and CEO Chris Thompson told Benzinga. “Our preliminary research has shown that CBD has a unique ability to block stress and anxiety, paving the way for TruBrain nootropics to deliver the most dramatic outcomes of mental endurance and break through procrastination.”
Related Links:
NBA Vet Turned Cannabis Exec Al Harrington Talks M Funding Round, Social Equity
3 Key Highlights From AxisWire’s 2019 Cannabis Trend Report
See more from Benzinga
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
